_parp-serwis.jpg "Parp Serwis from parp Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 30 sec
✓ Published: 14-Nov-2012
✓ Published: 14-Nov-2012
Description:
CreditsnCLIENT: PARPnAGENCY: Scholz & FriendsnPRODUCTION: Dorota SieradzkanANIMATION DIRECTOR: Michal Socha, BrosFXnCREATION: Agnieszka Niska- Wojcik, BrosFXnREALIZATION: BrosFX: Directing, Concept Design, Animation, Postproduction
CreditsnCLIENT: PARPnAGENCY: Scholz & FriendsnPRODUCTION: Dorota SieradzkanANIMATION DIRECTOR: Michal Socha, BrosFXnCREATION: Agnieszka Niska- Wojcik, BrosFXnREALIZATION: BrosFX: Directing, Concept Design, Animation, Postproduction
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_prostate-cancer-treatment-decisions-how-do-genetic-test-results-impact-your-options.webp "How do genetic test results impact prostate cancer treatment options? Dr. Nima Sharifi explains BRCA mutations, germline genes, and somatic mutations—and discusses when treatment with PARP inhibitors may be appropriate. Dr. Nima Sharifi is Director of the Genitourinary (GU) Malignancies Research Center at the Cleveland Clinic. Learn more here: https://www.lerner.ccf.org/cancerbio/sharifi/")
⏲ 2 min 54 sec ✓ 10-Dec-2020
_an-overview-of-metastatic-breast-cancer-treatment-options.webp "What metastatic breast cancer (MBC) treatment options are available? Dr. Jane Lowe Meisel provides an overview of MBC treatment approaches, including CDK4-6 inhibitors, tyrosine kinase inhibitors, PARP inhibitors, and immunotherapy.nnJane Lowe Meisel, MD is an Associate Professor of Hematology and Medical Oncology at Winship Cancer Institute at Emory University. Learn more about Dr. Meisel here: https://winshipcancer.emory.edu/bios/faculty/meisel-jane-l.html")
_negative-charge-and-poly-adp-ribosylation-a-scientific-animation.webp "A short 2D animation describing how a molecule, PARP-1, binds to DNA during the DNA repair process.")
_wicked-fart.webp "Muesli maketh the man.")
_e4-sting-2007.webp "My submission to the E4 stings competition 2007.")
_parp-inhibitor-monotherapy.webp "In this GU CONNECT programme, brought to you by Dr Neal Shore, you’ll follow a patient through their metastatic castration-resistant prostate cancer (mCRPC) journey and explore the clinical implementation of genetic testing and monotherapy treatment with a PARPi.nnWatch the 5-minute animated video and download the accompanying slides for an update on:nn- Efficacy and safety profiles of PARP inhibitors for prostate cancern- The role of genetic testing and how to use it to assess HRRm status and")
_esmo-e-learning-parp-inhibitors-past-present-and-future.webp "ESMO E-Learning: PARP Inhibitors: Past, Present and Future from parp")
_-nicotinamide-mononucleotide-1094-61-7-manufacturer-cofttek.webp "β-Nicotinamide Mononucleotide (1094-61-7) Manufacturer - Coftteknnhttps://www.cofttek.com/product/1094-61-7/nnβ-Nicotinamide Mononucleotide (NMN) SpecificationsnnnnName:nβ-Nicotinamide Mononucleotide (NMN)nnnCAS:n1094-61-7nnnPurityn98%nnnMolecular Formula:nC11H15N2O8PnnnMolecular Weight:n334.2208 g/molnnnMelt Point:n96°CnnnChemical name:n((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphatennnSynonyms:nNicotinamide Mononucleotide; NMN;")
_prostate-cancer-treatment-decisions-how-do-genetic-test-results-impact-your-options.jpg)
_an-overview-of-metastatic-breast-cancer-treatment-options.jpg)
_negative-charge-and-poly-adp-ribosylation-a-scientific-animation.jpg)
_wicked-fart.jpg)
_e4-sting-2007.jpg)
_parp-inhibitor-monotherapy.jpg)
_esmo-e-learning-parp-inhibitors-past-present-and-future.jpg)
_-nicotinamide-mononucleotide-1094-61-7-manufacturer-cofttek.jpg)
![[+]](/images/menu.gif){kind=small}